G enes play a moderate role in the etiology of depression, with twin-based heritability estimates ranging from 30% to 40% 1 and single-nucleotide polymorphism (SNP)-based heritability estimates ranging from 9% to 29%. [2] [3] [4] Large empirical studies of the genetic architecture of depression indicate that it is polygenic, meaning that the contribution of genetic factors is attributable to small effects of hundreds or thousands of genetic variants spread across the genome. 3, 5 To date, multiple studies have shown small but statistically significant associations between polygenic risk scores (PRSs) a weighted sum of the number of variants associated with the disorder in a different data set, and depression. [6] [7] [8] [9] However, these studies focused on prevalent depression, which is more likely than incident depression to be recurrent or chronic. 10, 11 Because the genome-wide association study (GWAS) data underpinning the PRSs are largely based on prevalent cases, this could suggest that part of the genetic architecture discovered in GWAS studies is linked to chronicity or recurrence rather than the risk of developing the disorder. Therefore, while the usefulness of PRSs as a measure of genetic liability for depression has been established, their association with depression in the general population remains, to our knowledge, relatively unexplored. In addition to heterogeneity in chronicity and recurrence, depression is also characterized by substantial variation in characteristics, such as age at onset (AAO) and symptom severity. Research suggests that this variation may be partially due to differences in genetic liability. Family studies demonstrate that individuals with a parental history of major depression (MD) are at increased risk for onset of depression at earlier ages, [12] [13] [14] [15] and recent results from the Psychiatric Genomics Consortium (PGC) showed that the polygenic risk for depression had a stronger association with early-onset vs late-onset depression. 4 Research also suggests that individuals with severe MD may have a higher genetic burden than individuals with milder symptoms. A recent GWAS in Han Chinese women found an increased genetic signal among individuals with melancholia, 16 and the PGC reported higher PRSs among severe vs moderate depression cases. 4 Our primary aim in this study was to evaluate the extent to which polygenic liability is associated with risk for first depressive episode in the general population. As a secondary aim, we examined whether polygenic liability is associated with severity and AAO at first depression diagnosis. Because prior evidence suggests a possible shared genetic etiology between depression and other psychiatric disorders, 2, 4, 17 we also examined the extent to which PRSs for bipolar disorder (BD) and schizophrenia (SZ) are associated with the risk for developing depression in the general population. To accomplish these aims, we used data from the iPSYCH2012 sample, a unique data set that links genetic information with longitudinal phenotype data from Danish national registers.
Methods

Study Design
For a detailed description of the iPSYCH2012 sample, see Pedersen et al. 18 Briefly, the iPSYCH2012 sample has a casecohort design 19 that consists of 2 parts: a random sample (ie, subcohort) of individuals drawn from a specified base population (ie, full cohort) and all additional cases from the full cohort that were not selected as part of the subcohort. Like a traditional cohort study, a case-cohort study can obtain accurate estimates of hazards and risks using a traditional survival analysis, provided the analyses are modified to address issues associated with point and variance estimations that are caused by oversampling cases. [19] [20] [21] [22] For a more detailed description of the case-cohort design see the eMethods in the Supplement. In the iPSYCH2012 sample, the subcohort consists of a random sample of 30 000 individuals drawn from the full cohort of all singletons born in Denmark between May 1, 1981, and December 31, 2005 , who were alive and living in Denmark on their first birthday and had known mothers (N = 1 472 762). 18 The full cohort was identified using information from the Danish Civil Registration system. 23 The iPSYCH2012 study includes all individuals from the full cohort who received a diagnosis of depression in a psychiatric hospital in Denmark between 1991 and 2012 at 10 years or older. 27 Quality control and imputation (using 1000 genomes as the reference panel) were conducted using the Ricopili pipeline. As the iPSYCH2012 sample is population based, individuals from the same nuclear family unit were neither purposely sampled nor purposely removed.
Measures
The AAO was operationalized as the individual's age in years at first F32 diagnosis in the DCPRR. Information on severity was obtained from ICD-10 diagnostic codes (mild, F32.0; moderate, F32.1; severe without psychotic features, F32.2; and severe with psychotic features, F32.3). We also examined differences in treatment settings (inpatient, emergency, and outpatient) as cases treated in inpatient or emergency settings are likely more severe than cases treated in an outpatient setting. Polygenic risk scores were calculated using a standard approach 28 in which a linkage disequilibrium-pruned discovery data set is used to identify autosomal SNPs associated with the outcome at varying P value thresholds, and then a score is calculated for individuals in a target data set that corresponds to the weighted sum of each participant's allelic burden at that threshold. Polygenic risk scores for MD and SZ were created using the Ricopili process with the most recently published GWAS results from the PGC (not including iPSYCH2012) as discovery data sets. 4, 29 The discovery data set for BD was composed of leave one out summary statistics provided in advance of the latest GWAS publication from the Bipolar Working Group of the PGC.
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Single-nucleotide polymorphisms from the discovery data sets were filtered at an INFO score of more than 0.9 and a minor allele frequency of more than .05, and the broad major histocompatibility complex region (chr6: 25-35 MB) was removed. Additionally SNPs were only included in the scores if they were reliably genotyped or imputed across all 23 waves of the iPSYCH2012 sample, at an INFO score of more than 0.6 and a minor allele frequency of more than .01. Ten PRSs were calculated for each disorder (30 total) at the following P value thresholds: P < . 00000005, .000001, .0001, .001, .01, .05, .10, .20, .50, and >.99 (see eTable 1 in the Supplement for SNP numbers).
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Polygenic risk scores were standardized using the means and SDs from the distributions in subcohort members with Danish ancestry (eFigure in the Supplement). As the iPSYCH2012 subcohort is a simple random sample drawn from the base population, the distribution of PRSs in the subcohort approximates the distribution in the Danish-born population.
Statistical Analysis
The hazard of depression was estimated using Cox regressions with days since the participant's tenth birthday as the timescale. Individuals entered the analysis on their tenth birthday and were censored on the date of their first F32 diagnosis in the DCPRR, death, emigration, or December 31, 2012, whichever came first. The oldest participants were age 31 years when they received their diagnosis or were censored. We used robust standard errors and Barlow weighting to account for oversampling of cases. 22, 32 All models were adjusted for sex and the top 4 ancestral principal components (PCs). Additionally, all models were stratified by birth year to control for secular trends in diagnostic practices and because fewer bloodspots were retrievable among individuals born during earlier years. To examine whether polygenic liability has a stronger association with early-onset depression, we conducted separate Cox regressions in each analysis with only depression with onset in a specific age range considered as an outcome. Thus, we estimated separately the association of PRSs with hazard of depression with diagnosis at ages 10 to 15, 16 to 20, 21 to 25, and 26 to 31 years, respectively. Likewise, we conducted separate Cox regressions that considered respectively mild, moderate, severe without psychotic features, severe with psychotic features, inpatient, emergency and outpatient treatment setting at first depression as outcomes in each of the analyses. We also examined the associations between PRSs, AAO, and severity among cases only. Associations with AAO in days were estimated using linear regressions. Associations with severity measures were estimated using multinomial logistic regressions. All case-only regressions were adjusted for the first 4 PCs, sex, and birth year. Statistical significance was assessed at the Bonferroni-corrected α-level P < .017. Analyses were conducted in SAS, version 9.4 (SAS Institute; eAppendix in the Supplement). Table 1 shows sample characteristics. Of the participants without depression, 9659 (48.9%) were female, which was expected given that the subcohort is a representative sample of the Danish population. Of the participants with MD, 10 056 (68.0%) were female, which was also expected given that the typical female to male ratio of depression in the population is 2:1. 33 The AAO ranged from 10 to 31 years, with a mean (SD) of 19.1 (4.1) years. Seventeen percent of the cases were classified as mild (n = 2573), 45% as moderate (n = 6635), 9% as severe (n = 1386), 3% as psychotic (n = 481), and 25% had no ICD-10 severity specification (n = 3724). Most (60%; n = 8880) were treated in an outpatient setting.
Results
Sample Characteristics
Polygenic Liability and Hazard of Depression
For all 3 PRSs (PRS-MD, PRS-BD, and PRS-SZ), the strength of the association increased as the stringency of the P value threshold decreased up to P<.05 (eTable 2 and eFigures 2-7 in the Supplement). For this reason, and to maintain consistency with prior research, we present results from the P<.05 thresholds throughout this article. Each SD increase in PRS-MD was associated with a 30% increase in the hazard of depression (95% CI, 1.27-1.33; P < .0001). Compared with an individual with average polygenic liability, an individual who is 1 SD more than the population average had a 30% increased risk of receiving a depression diagnosis before age 31 years. The corresponding values for PRS-BD and PRS-SZ were 5% (95% CI, 1.02-1.07; P < .0001) and 12% (95% CI, 1.09-1.15; P < .0001), respectively (eTable 2 in the Supplement). Figure 1 shows the associations between PRS deciles and the hazard of depression, with the bottom decile (ie, the lowest 10% of the PRS distribution) as the reference category. Compared with individuals in the bottom decile, individuals in the top decile of PRS-MD had a hazard ratio of 2.55 (95% CI, 2.28-2.85; P < .0001). The corresponding values were 1.22 (95% CI, 1.10-1.36; P < .0001) for PRS-BD and 1.49 (95% CI, 1.34-1.66; P < .0001) for PRS-SZ (eTable 3 in the Supplement).
AAO
As shown in Figure 2 and Table 2 , the hazard of depression per SD increase in PRS-MD was slightly higher for first diagnosis between age 16 to 20 years (1.31; 95% CI, 1.27-1.35) and age 21 to 25 years (1.32; 95% CI, 1.27-1.38) compared with age 10 to 15 years (1.27; 95% CI, 1.22-1.33) or age 26 to 31 years (1.24; 95% CI, 1.16-1.32). The hazard ratio of PRS-BD was highest for diagnosis between ages 10 to 15 years (1.08; 95% CI, 1.04-1.12) and decreased linearly with age. The hazard ratio between PRS-SZ and was highest for diagnoses between age 10 to 15 years (1.17; 95% CI, 1.12-1.22) and lowest for diagnoses between age 21 to 25 years (1.08; 95% CI, 1.04-1.13). Case-only analyses showed small associations between higher PRSs and earlier AAO across all scores, but only the association for PRS-BD survived correction for multiple testing ( Table 3) .
Severity
The hazard ratios for PRS-MD, PRS-BD, and PRS-SZ were highest for psychotic depression ( Figure 2 , Table 2 ). The differences by severity were most pronounced for PRS-SZ (1.20; 95% CI, 1.09-1.32) and least pronounced for PRS-MD (1.33; 95% CI, 1.23-1.45). In the case-only analyses, none of the associations were statistically significant; however, the association between higher PRS-SZ and an increased odds of psychotic depression was suggestive (odds ratio, 1.10; 95% CI, 1.00-1.21; P = .06) ( Table 3) .
The hazard ratios for PRS-MD, PRS-BD, and PRS-SZ were higher for treatment in inpatient and emergency settings; however, these differences were small ( Figure 2 ). Polygenic risk scores for MD were marginally associated with an increased odds of emergency treatment in the case-only analyses (odds ratio, 1.05; 95% CI, 1.01-1.09; P = .02) ( Table 3 ).
Discussion
In this study, we found that PRSs trained using aggregated results from selected samples of prevalent, often recurrent depression cases contributed to the risk for first depression in the Danish general population. For each SD increase in polygenic liability, the hazard of depression increased by 30%. Compared with individuals in the bottom 10% of the polygenic liability distribution, the hazard of depression was 2.55 times higher among individuals in the top 10%. These results suggest that estimates of genetic liability ascertained using prevalent samples are tapping in to an underlying genetic predisposition for developing depression, not just a predisposition to maintain the disorder once it has been established. Polygenic liability for BD and SZ were associated with depression to a lesser extent than PRS-MD, which supports the well- documented finding that these disorders share some common genetic etiology. The association of polygenic liability with AAO in this study was much smaller than prior findings from family studies would suggest. This could reflect that PRSs and family background are not entirely overlapping measures of genetic risk. Previous research suggests that some of the effect of family history of schizophrenia is mediated by polygenic risk. 34 If the same holds true for depression, the larger effects identified in family studies may be attributable to the portion of the family history effect not captured by a PRS, or possibly to an increased vigilance for psychiatric disorders among multiplex families. The oldest members of the iPSYCH2012 cohort were only age 31 years at the end of follow-up, which is around the median age of onset for depression. 35 As a result, the entire sample could be considered early-onset. It may be that the more pronounced differences exist in the effects of PRS-MD with the risk for depression at different points across the lifespan, but that these differences are less apparent when comparing groups of younger individuals. We found little association between polygenic liability and greater severity at the initial depression diagnosis, which is inconsistent with recent findings from the PGC. 4 In general, past studies with positive findings in this area have focused on severity measures that are associated with the illness course, such as the number of depressive episodes and the chronicity of depressive symptoms. [36] [37] [38] It could be that polygenic liability has less of an effect on characteristics of the first depressive episode than it does on the characteristics of course. It has been suggested previously that stratifying on the phenotype may be a viable method to increase statistical power for identifying genetic variants that are associated with depression. 39 This method has been used with some success by the CONVERGE consortium, which identified a locus that was significantly associated with depression in Han Chinese women by selecting for highly severe, recurrent female cases.
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Polygenic risk was also found to be differentially associated with subtypes in autism, 31 BD, and SZ. 30 However, for depression, greater success in gene discovery was achieved by increasing the sample size at the expense of a carefully defined phenotype. 4, 40 In this vein, the results of this study indicate that the usefulness of further stratification on the phenotype for gene discovery in depression might be more limited than we may have wished.
We found some evidence of genetic heterogeneity among depression cases in terms of polygenic liabilities for BD and SZ: there was a suggestive (although not significant) association between PRS-SZ and depression with psychotic symptoms, which makes intuitive sense. The PRS for BD was significantly associated with earlier age at MD onset in the caseonly analyses, and the case-cohort analyses in separate age groups suggest that PRS-BD and PRS-SZ may be particularly elevated among individuals who receive a diagnosis with MD between the ages of 10 to 15 years. These results are consistent with past studies 41, 42 and could suggest that a person's degree of genetic liability for BD or SZ may place them at an increased risk for different clinical manifestations of depression. However, psychiatric diagnoses are often unstable over time, and both early AAO and greater severity/psychotic symptoms are robust risk factors for converting to BD or SZ.
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It is therefore possible that these results reflect that many individuals with BD and SZ receive a depression diagnosis during the early stages of their illness.
Strengths and Limitations
The iPSYCH2012 sample has many strengths, including a large sample size, population-based sampling, and a uniform case definition. The fact that cases were identified through clinical records rather than selected specifically for research increases the relevance for clinical practice. In addition, the ancestral homogeneity of the Danish population reduces the likelihood of confounding by population stratification.
However, it should be noted that although cases in the iPSYCH2012 sample are representative of individuals who received treatment for depression in psychiatric hospitals, they do not include people with depression who are untreated or only treated by general practitioners. 46, 47 To put this into perspective, currently unpublished results show that most (85%) individuals who are medically treated for depression in Denmark are treated first by their primary care doctors, although this proportion was lower in younger age groups (unpublished data, 2018) . The cases in the iPSYCH2012 sample therefore represent the severe end of the depression distribution in Denmark, which is both a strength and a limitation. Severe cases are likely enriched for genetic determinants 16 ;h o wever, the results may not generalize to milder forms of depression, and they could be biased toward the null because of misclassification. Additionally, there may be too little variation in severity to assess the associations between polygenic liability and severity in this sample. The analyses may also be subject to selection bias if people with specialty-treated depression are more likely than people with untreated or primary-care treated depression to experience recurrent episodes. Because we focused exclusively on first depression, we did not account for subsequent diagnostic conversions to BD or SZ. Individuals who convert may have different genetic profiles; however, there was no way to account for this without conditioning on the future, which can introduce bias.
48 Further research is needed to investigate the associations between polygenic liability and the characteristics of course and outcome, including progression to other psychiatric disorders. Finally, the discovery data sets used to create the polygenic risk scores for MD, BD, and SZ had different sample sizes, which affects their statistical power.
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Conclusions
We found that polygenic liability is associated with depression in the general Danish population. Polygenic liabilities for BD and SZ were also associated with depression, which supports the idea that there is a shared genetic predisposition across these disorders. Heterogeneity in AAO might be partially attributable to underlying genetic differences among depression cases, but these associations appear minimal. 
eMethods: The Case-Cohort Study Design
In a traditional cohort study, individuals are selected irrespective of case status and then followed forward in time to determine who does and does not develop the outcome (i.e. become a case). The figure below depicts a hypothetical cohort study containing 5 individuals, 2 of whom (denoted by the circles) develop the outcome of interest during the follow-up period.
Risk or hazard is calculated by comparing the number of individuals who experience the outcome at a specific point in time (numerator) with the number of individuals at risk at that time (denominator).
The set of individuals at risk for the event at the time a study member experiences the event is called the A case-cohort design is nested within a larger cohort, with a sample consisting of two parts: a smaller cohort of individuals randomly sampled from a full cohort (i.e. the 'subcohort'), and all additional cases in the full cohort who were not selected as part of the subcohort. It should be noted that the subcohort does not constitute 'controls' per se -the subcohort includes both individuals who develop the outcome (cases) and individuals who do not develop the outcome (non-cases). If the subcohort is a simple random sample from the full cohort, it will contain a distribution of cases and non-cases that is equivalent to that of the full cohort. The study sample is then supplemented by adding in all of the cases from the full cohort who were not selected as part of the subcohort. Therefore, all of the non-cases in a case-cohort design are members of the subcohort, while the cases can be members of the subcohort, or they can be outside the subcohort.
The fact that a case-cohort design oversamples cases presents an analytic challenge -how can cases outside the subcohort be included in the analyses without biasing the estimates of risk? The answer lies in the formulation of the risk sets. When analyzing a case-cohort study, only individuals in the subcohort (cases and non-cases) contribute to the risk sets for other individuals. Cases outside the subcohort enter the analyses at the moment they experience the outcome, therefore they only contribute to the analysis at the point in time when they, themselves, become a case.
Full Cohort Subcohort Cases
Cases inside the subcohort © 2019 American Medical Association. All rights reserved.
In the illustration above, person 2 is a case inside the subcohort, and person 4 is a case outside the subcohort.
Note that person 4 no longer contributes to the risk set for person 2, even though he or she experiences the event after person 2.
Proper analysis of case-cohort data is accomplished using a traditional cox regression model, modified in several ways to accommodate the oversampling of cases. First, a case-cohort cox model uses a pseudolikelihood function instead of a partial likelihood function. This is accomplished by incorporating a weighting scheme into the analysis to ensure that cases outside the subcohort contribute appropriately.
Different weighting schemes for estimating covariate effects in case-cohort studies have been proposed by Prentice (1), Self and Prentice (2) , Kalbfleich and Lawless (3), Barlow et al. (4) , Therneau and Li (5) , and
Chen and Lo (6) . These weighting schemes were compared by Petersen and colleagues (7), who found that the estimators based on different weighting schemes did not differ substantially. The variance estimates must also be modified to accommodate oversampling of cases. One variance estimator was proposed by Self and Prentice (2) , while Barlow (8) and Lin (9) proposed a robust variance estimator.
For further information on the design and analysis of case-cohort studies see the following:
(1) Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. /* Identify all IC-10 MDD diagnoses in the Psychiatric Register */ data pcr_mdd; set pcr (keep=IDvar idato bday10 ptype adiag at1-at3 gdiag gt1-gt3 b1dia2 b2dia2 b3dia2 b4dia2 b5dia2 b6dia2 b7dia2 b8dia2 b9dia2 b10dia2 b11dia2 b12dia2 b13dia2 b14dia2 b15dia2 b16dia2 b17dia2 b18dia2 b1t1-b1t3 b2t1-b2t3 b3t1-b3t3 b4t1-b4t3 b5t1-b5t3 b6t1-b6t3 b7t1-b7t3 b8t1-b8t3 b9t1-b9t3 b10t1-b10t2 b11t1-b11t2); array diag[*] adiag at1-at3 gdiag gt1-gt3 b1dia2 b2dia2 b3dia2 b4dia2 b5dia2 b6dia2 b7dia2 b8dia2 b9dia2 b10dia2 b11dia2 b12dia2 b13dia2 b14dia2 b15dia2 b16dia2 b17dia2 b18dia2 b1t1-b1t3 b2t1-b2t3 b3t1-b3t3 b4t1-b4t3 b5t1-b5t3 b6t1-b6t3 b7t1-b7t3 b8t1-b8t3 b9t1-b9t3 b10t1-b10t2 b11t1-b11t2; 
